In Japan, the incidence of prostate cancer has increased in recent years, partially due to the popularity of prostate-specific antigen (PSA) screening; the reported incidence was 92,021 in 2018, making it the most commonly diagnosed cancer, surpassing stomach, colorectal, and lung cancers [1]. The gene discussed is KLK3; the disease is lung carcinoma.